StockWatch
·
Specialty Chemicals
Board Meeting31 Oct 2026, 12:00 pm

Valiant Organics Board Meeting on Nov 5 to Approve Financial Results

AI Summary

Valiant Organics Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Additionally, the board may discuss any other business matters with the Chair's permission. The trading window for company securities will remain closed until November 7, 2026, to facilitate these processes.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve Unaudited financial results for Q2 FY27.
  • Results will cover both standalone and consolidated financials.
  • Trading window closure until November 7, 2026.